Search Tag: Pharmaceutical

Executive Health Management

Ratio Therapeutics Appoints Jacob Hesterman, Ph.D., as Chief Data Officer

2022 15 Sep

 Ratio Therapeutics Inc., a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancers announced the appointment of  Jacob Hesterman , Ph.D., as the company's Chief Data Officer (CDO). In this newly created role, Dr. Hesterman will build the company's data... Read more

Executive Health Management

CPhI Worldwide 2022

2022 01 Nov

Find CPhI On Social Media Read more

Executive Health Management

Johnson & Johnson to Split into Two Companies; Shares Rise

2021 12 Nov

Health-care giant Johnson & Johnson is splitting off its consumer division, following in the footsteps of other big drugmakers that have moved to focus on the more-profitable pharmaceutical market.   The consumer division will be separated in 18 to 24 months, the company said in a statement. The unit has been beset by lawsuits involving products... Read more

Executive Health Management

Kazakhstan International Healthcare Exhibition - KIHE 2022

2022 18 May

Find KIHE On Social Media       Read more

Executive Health Management

FT Global Pharmaceutical and Biotechnology Conference 2021

2021 08 Nov

Find FT Lives on Social Media           Read more

Health Management

Think Global, Act Local in Healthcare Communications

2020 30 Nov

The pharmaceutical and medical device sectors strive to deliver global communications strategies relating to their innovative products and how they can benefit patients, their carers and health systems. However, as COVID-19 has once again demonstrated, although we are global citizens, at a country level there is still very much a nationalistic... Read more

IT Management

First AI-Created Drug Trial

2020 14 Feb

  For the first time, an AI-made drug has reached the clinical trials stage.   Called DSP-1181, the pharmaceutical drug created by AI technology to treat obsessive-compulsive disorder, is in phase 1 trials in Japan.   You might also like: EIT Awards €6 mln to Health Start-ups   The drug is a result of UK-based Exscientia.... Read more